Skip to main contentSkip to navigationSkip to search
ENZY  
SEK  %
Logotype
ENZY  
SEK  %
Logotype

Media

Press releases

2022

November 1, 2022 - Non-regulatory press release
New study confirms ColdZyme stops viruses causing Covid-19 from adhering to human respiratory cells
August 26, 2022 - Regulatory press release
Enzymatica announces outcome of new rights issue
August 18, 2022 - Regulatory press release
Enzymatica publishes supplementary prospectus
August 16, 2022 - Regulatory press release
ColdZyme also blocks omicron variants BA.4 and BA.5
August 5, 2022 - Regulatory press release
Publication of prospectus regarding Enzymatica’s rights issue
July 19, 2022 - Regulatory press release
Interim report Q2/2022: Improved sales give confidence for the future
July 19, 2022 - Regulatory press release
Enzymatica’s Board of Directors decides on a new rights issue of SEK 74.7 million
June 23, 2022 - Regulatory press release
ColdZyme blocks omicron virus – according to new research
June 16, 2022 - Regulatory press release
Enzymatica signs loan agreement with major shareholders
April 28, 2022 - Regulatory press release
Bulletin from Annual General Meeting of Enzymatica AB (publ) on 28 April 2022
April 28, 2022 - Regulatory press release
Interim report Q1/2022: Our financial targets remain in place
April 11, 2022 - Non-regulatory press release
Article about ColdZyme acquitted from suspicions of research misconduct
April 4, 2022 - Non-regulatory press release
Enzymatica’s mouth spray to be launched in Turkey
March 31, 2022 - Regulatory press release
Enzymatica publishes annual report for 2021
March 28, 2022 - Regulatory press release
Notice of Annual General Meeting 2022 in Enzymatica AB (publ)
March 3, 2022 - Non-regulatory press release
Enzymatica’s mouth spray to be launched in Mexico
February 17, 2022 - Regulatory press release
Year-end report: Clear signs of favourable market trends after a challenging 2021
January 12, 2022 - Non-regulatory press release
Enzymatica comments on wrongful wording in Dagens Medicin

2021

November 2, 2021 - Regulatory press release
The long-term plan remains in challenging times
November 2, 2021 - Regulatory press release
Enzymatica Board decides on financial targets
Load more